Insider Trading June 10, 2026 06:40 PM

U.S. Physical Therapy Director Peter Minan Buys $48,776 in Stock Amid Recent Earnings Miss

Executive acquisition occurs as the healthcare services company trades near its 52-week low, despite analyst price targets suggesting significant upside potential.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
USPH

Peter Francis Minan, a director at U.S. Physical Therapy Inc. (NASDAQ: USPH), has executed a series of share purchases totaling $48,776 over a two-day period in June 2026. This activity takes place against a backdrop of recent financial results that fell short of market expectations, with the company's stock trading near its 52-week low. Despite the recent earnings miss, the director's direct holdings now stand at 3,211 shares, which include a portion of restricted stock tied to his continued service on the board.

U.S. Physical Therapy Director Peter Minan Buys $48,776 in Stock Amid Recent Earnings Miss
USPH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Peter Minan acquired 492 shares on June 8, 2026, at $63.14 per share and 288 shares on June 9, 2026, at $61.50 per share.
  • U.S. Physical Therapy reported a Q1 2026 GAAP loss of $0.12 per share, missing analyst expectations of $0.54, with revenue of $198 million falling short of the $200.26 million forecast.
  • Minan's direct holdings now total 3,211 shares, including 2,306 restricted shares that vest in installments through March 2027, contingent on his continued service as a director.

Peter Francis Minan, serving as a director at U.S. Physical Therapy Inc. (NASDAQ: USPH), has executed a series of share purchases totaling $48,776 over a two-day period in June 2026. This activity takes place against a backdrop of recent financial results that fell short of market expectations, with the company's stock trading near its 52-week low. Despite the recent earnings miss, the director's direct holdings now stand at 3,211 shares, which include a portion of restricted stock tied to his continued service on the board.


According to a Form 4 filing, Minan purchased 492 shares of common stock on June 8, 2026, at a price of $63.14 per share. The following day, June 9, 2026, he acquired an additional 288 shares at $61.50 each. Following these purchases, Minan directly holds 3,211 shares of U.S. Physical Therapy common stock. The purchases come as USPH trades near its 52-week low of $58.19, while analysts maintain price targets ranging from $88 to $100, suggesting potential upside from current levels around $62.83.


This total includes 2,306 shares of restricted stock granted under the company's Amended and Restated 2003 Stock Incentive Plan. These restricted shares are scheduled to vest in installments: 1,153 shares on August 20, 2026, 576 shares on November 20, 2026, and 577 shares on March 6, 2027, contingent on his continued service as a director. According to InvestingPro, the company has maintained dividend payments for 16 consecutive years, with 6 additional ProTips available for subscribers.


In other recent news, U.S. Physical Therapy, Inc. reported its first-quarter 2026 earnings, which fell short of expectations. The company posted a GAAP loss per share of $0.12, while analysts had anticipated earnings of $0.54 per share. Additionally, revenue for the quarter was reported at $198 million, slightly missing the forecast of $200.26 million. These results were followed by a negative response in the aftermarket. In other developments, shareholders at U.S. Physical Therapy's annual meeting approved all proposals presented. The election of seven directors was confirmed, with each receiving significant support from shareholders. These recent developments provide insights into the company's current financial and governance status.


The acquisition of stock by a director, particularly during a period where the stock price is near its 52-week low, may signal internal confidence in the company's long-term prospects. However, the recent earnings miss and subsequent negative aftermarket response highlight the challenges the company faces in meeting market expectations. The restricted stock vesting schedule further ties the director's financial interests to the company's continued service, aligning his incentives with the company's governance and operational stability.

Risks

  • The company's recent earnings miss and negative aftermarket response indicate potential challenges in meeting market expectations, which could impact investor sentiment and stock volatility.
  • The stock trading near its 52-week low of $58.19 suggests ongoing market pressure, despite analyst price targets ranging from $88 to $100, highlighting a disconnect between current market valuation and analyst projections.

More from Insider Trading

Manhattan Associates CEO Eric Clark Executes $146,770 Stock Sale Amid Strategic Shifts Jun 10, 2026 GoDaddy CFO Sells $290K in Shares Amid AI Expansion and Market Volatility Jun 10, 2026 Snowflake Product Executive Executes Stock Sales Under Pre-Arranged Plan Jun 10, 2026 AXT Inc. Director Jesse Chen Offloads $1.48 Million in Shares Amid Stock Volatility Jun 10, 2026 Chime Financial's General Counsel Executes Stock Sale Amid Fintech Sector Volatility Jun 10, 2026